Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Mepolizumab and Eosinophil-Mediated Disease

Volume:16   Issue:36
Pp: 4774-4778
G. M. Walsh
DOI: 10.2174/092986709789909639

Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives

Volume:16   Issue:36
Pp: 4779-4796
S. Mocellin, P. Pilati and D. Nitti
DOI: 10.2174/092986709789909648

Overview of Naphthalimide Analogs as Anticancer Agents

Volume:16   Issue:36
Pp: 4797-4813
Min Lv and Hui Xu
DOI: 10.2174/092986709789909576

The Potential of Embryonic Stem Cells Combined with -omics Technologies as Model Systems for Toxicology

Volume:16   Issue:36
Pp: 4814-4827
J. Winkler, I. Sotiriadou, S. Chen, J. Hescheler and A. Sachinidis
DOI: 10.2174/092986709789909657

Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives

Volume:16   Issue:36
Pp: 4828-4842
F. Fulop, I. Szatmari, E. Vamos, D. Zadori, J. Toldi and L. Vecsei
DOI: 10.2174/092986709789909602

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Volume:16   Issue:36
Pp: 4858-4868
F. Di Pauli, T. Berger and M. Reindl
DOI: 10.2174/092986709789909585

Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment

Volume:16   Issue:36
Pp: 4869-4888
Ning Liu, Hao Fang, Yanling Li and Wenfang Xu
DOI: 10.2174/092986709789909611